NRBF2 has been reported to be necessary for learning and memory (Ouyang et al., 2020), as well as cognitive impairment in Alzheimer’s disease (AD) patients (Yang et al., 2017; Lachance et al., 2019). Here, NRBF2 is linked to early-onset autosomal dominant Alzheimer disease.